Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -237,734 | -129,874 | -79,413 | -110,715 | -41,873 |
| Depreciation Amortization | -10,968 | 45 | 1,085 | 576 | -144 |
| Accounts receivable | N/A | N/A | N/A | N/A | -84 |
| Accounts payable and accrued liabilities | -12,040 | 11,524 | 1,655 | -426 | 525 |
| Other Working Capital | -9,425 | 15,962 | 1,724 | 4,427 | 1,651 |
| Other Operating Activity | 85,997 | 8,505 | 20,368 | 76,359 | 3,869 |
| Operating Cash Flow | $-184,170 | $-93,838 | $-54,581 | $-29,779 | $-36,056 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -93,354 | -114,329 | -74,033 | -79,807 | 28,310 |
| PPE Investments | -898 | -797 | -259 | -42 | -84 |
| Net Acquisitions | N/A | N/A | N/A | 29,371 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -3 | 0 |
| Investing Cash Flow | $-94,252 | $-115,126 | $-74,292 | $-50,481 | $28,226 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 1,726 | N/A |
| Debt Issued | 15,000 | 5,000 | N/A | N/A | N/A |
| Common Stock Issued | 146,793 | 295,754 | 116,593 | 25,104 | 2,480 |
| Common Stock Repurchased | N/A | N/A | N/A | -44 | N/A |
| Other Financing Activity | 63,877 | 21,490 | 8,682 | 74,525 | -2,410 |
| Financing Cash Flow | $225,670 | $322,244 | $125,275 | $101,311 | $70 |
| Beginning Cash Position | 155,579 | 42,299 | 45,897 | 24,846 | 32,606 |
| End Cash Position | 102,827 | 155,579 | 42,299 | 45,897 | 24,846 |
| Net Cash Flow | $-52,752 | $113,280 | $-3,598 | $21,051 | $-7,760 |
| Free Cash Flow | |||||
| Operating Cash Flow | -184,170 | -93,838 | -54,581 | -29,779 | -36,056 |
| Capital Expenditure | -898 | -797 | -338 | -42 | -84 |
| Free Cash Flow | -185,068 | -94,635 | -54,919 | -29,821 | -36,140 |